These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 17189954

  • 21. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
    Solan AN, Cesaretti JA, Stone NN, Stock RG.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1468-74. PubMed ID: 18922652
    [Abstract] [Full Text] [Related]

  • 22. Use of medications or devices for erectile dysfunction among long-term prostate cancer treatment survivors: potential influence of sexual motivation and/or indifference.
    Miller DC, Wei JT, Dunn RL, Montie JE, Pimentel H, Sandler HM, McLaughlin PW, Sanda MG.
    Urology; 2006 Jul 01; 68(1):166-71. PubMed ID: 16844457
    [Abstract] [Full Text] [Related]

  • 23. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study.
    Stephenson RA, Mori M, Hsieh YC, Beer TM, Stanford JL, Gilliland FD, Hoffman RM, Potosky AL.
    J Urol; 2005 Aug 01; 174(2):646-50; discussion 650. PubMed ID: 16006930
    [Abstract] [Full Text] [Related]

  • 24. Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy.
    Taussky D, Haider M, McLean M, Yeung I, Williams T, Pearson S, Lockwood G, Crook J.
    Brachytherapy; 2004 Aug 01; 3(3):125-9. PubMed ID: 15533803
    [Abstract] [Full Text] [Related]

  • 25. Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapy.
    McDonald AM, Baker CB, Shekar K, Popple RA, Clark GM, Yang ES, Jacob R, Kim RY, Fiveash JB.
    Urology; 2014 Dec 01; 84(6):1383-7. PubMed ID: 25440987
    [Abstract] [Full Text] [Related]

  • 26. Radiation therapy for prostate cancer and erectile (dys)function: the role of imaging.
    Incrocci L.
    Acta Oncol; 2005 Dec 01; 44(7):673-8. PubMed ID: 16227156
    [Abstract] [Full Text] [Related]

  • 27. Novel prostate brachytherapy technique: improved dosimetric and clinical outcome.
    Nobes JP, Khaksar SJ, Hawkins MA, Cunningham MJ, Langley SE, Laing RW.
    Radiother Oncol; 2008 Jul 01; 88(1):121-6. PubMed ID: 18499289
    [Abstract] [Full Text] [Related]

  • 28. Nursing considerations in brachytherapy-related erectile dysfunction.
    Stipetich R, Abel LJ, Anderson RL, Butler WM, Wallner KE, Merrick GS.
    Urol Nurs; 2005 Aug 01; 25(4):249-54; quiz 259. PubMed ID: 16225341
    [Abstract] [Full Text] [Related]

  • 29. The prevalence of erectile dysfunction among Brazilian men screened for prostate cancer.
    Paranhos M, Antunes A, Andrade E, Freire G, Srougi M.
    BJU Int; 2009 Oct 01; 104(8):1130-3. PubMed ID: 19426190
    [Abstract] [Full Text] [Related]

  • 30. Health-related quality of life after intensity modulated radiation therapy for localized prostate cancer: comparison with conventional and conformal radiotherapy.
    Namiki S, Ishidoya S, Tochigi T, Kawamura S, Kuwahara M, Terai A, Yoshimura K, Numata I, Satoh M, Saito S, Takai Y, Yamada S, Arai Y.
    Jpn J Clin Oncol; 2006 Apr 01; 36(4):224-30. PubMed ID: 16537689
    [Abstract] [Full Text] [Related]

  • 31. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.
    DiBlasio CJ, Malcolm JB, Derweesh IH, Womack JH, Kincade MC, Mancini JG, Ogles ML, Lamar KD, Patterson AL, Wake RW.
    BJU Int; 2008 Jul 01; 102(1):39-43. PubMed ID: 18294309
    [Abstract] [Full Text] [Related]

  • 32. Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer.
    Namiki S, Ishidoya S, Ito A, Tochigi T, Numata I, Narazaki K, Yamada S, Takai Y, Arai Y.
    Jpn J Clin Oncol; 2009 Nov 01; 39(11):732-8. PubMed ID: 19666904
    [Abstract] [Full Text] [Related]

  • 33. Potency preservation following stereotactic body radiation therapy for prostate cancer.
    Obayomi-Davies O, Chen LN, Bhagat A, Wright HC, Uhm S, Kim JS, Yung TM, Lei S, Batipps GP, Pahira J, McGeagh KG, Collins BT, Kowalczyk K, Bandi G, Kumar D, Suy S, Dritschilo A, Lynch JH, Collins SP.
    Radiat Oncol; 2013 Nov 01; 8():256. PubMed ID: 24180317
    [Abstract] [Full Text] [Related]

  • 34. Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: mature prospective phase I/II study results.
    Duchesne GM, Williams SG, Das R, Tai KH.
    Radiother Oncol; 2007 Aug 01; 84(2):128-34. PubMed ID: 17561293
    [Abstract] [Full Text] [Related]

  • 35. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
    Zelefsky MJ, Nedelka MA, Arican ZL, Yamada Y, Cohen GN, Shippy AM, Park JJ, Zaider M.
    Brachytherapy; 2008 Aug 01; 7(1):1-6. PubMed ID: 18299108
    [Abstract] [Full Text] [Related]

  • 36. A comparison of radiation dose to the bulb of the penis in men with and without prostate brachytherapy-induced erectile dysfunction.
    Merrick GS, Wallner K, Butler WM, Galbreath RW, Lief JH, Benson ML.
    Int J Radiat Oncol Biol Phys; 2001 Jul 01; 50(3):597-604. PubMed ID: 11395225
    [Abstract] [Full Text] [Related]

  • 37. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer.
    Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA.
    J Urol; 2007 Jun 01; 177(6):2151-6; discussion 2156. PubMed ID: 17509305
    [Abstract] [Full Text] [Related]

  • 38. The early use of transurethral alprostadil after radical prostatectomy potentially facilitates an earlier return of erectile function and successful sexual activity.
    Raina R, Pahlajani G, Agarwal A, Zippe CD.
    BJU Int; 2007 Dec 01; 100(6):1317-21. PubMed ID: 17850385
    [Abstract] [Full Text] [Related]

  • 39. Patterns of local failure following prostate brachytherapy.
    Stone NN, Stock RG, White I, Unger P.
    J Urol; 2007 May 01; 177(5):1759-63; duscussion 1763-4. PubMed ID: 17437808
    [Abstract] [Full Text] [Related]

  • 40. Prevalence of erectile dysfunction in men screened for prostate cancer.
    Bianco FJ, McHone BR, Wagner K, King A, Burgess J, Patierno S, Jarrett TW.
    Urology; 2009 Jul 01; 74(1):89-93. PubMed ID: 19428072
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.